Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Humacyte, Inc. - Common Stock
(NQ:
HUMA
)
1.080
-0.060 (-5.26%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Humacyte, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday
↗
April 19, 2024
Via
Benzinga
Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday
↗
April 18, 2024
Via
Benzinga
Tommy Tuberville Trades Raise Eyebrows Again: Senator Sells Put Options, Buys Small Biotech Linked To Ukraine-Russia War
↗
April 17, 2024
Tommy Tuberville is one of the most active traders as a member of Congress. Here's a look at what he recently bought and sold.
Via
Benzinga
HUMA Stock Earnings: Humacyte Meets EPS for Q4 2023
↗
March 22, 2024
HUMA stock results show that Humacyte met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Preview: Humacyte
↗
March 21, 2024
Via
Benzinga
Why Humacyte (HUMA) Shares Are Falling
↗
March 01, 2024
Humacyte shares are trading lower by 29.2% during Friday's session. The company announced pricing of a $40.2 million public offering of common stock.
Via
Benzinga
Humacyte: Q3 Earnings Insights
↗
November 09, 2023
Via
Benzinga
Earnings Scheduled For March 22, 2024
↗
March 22, 2024
Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million.
Via
Benzinga
Investor Optimism Improves Slightly; Dow Jumps Over 250 Points
↗
March 22, 2024
The CNN Money Fear and Greed index showed a slight increase in the overall market sentiment on Thursday.
Via
Benzinga
Topics
Stocks
Senator Tommy Tuberville's Latest 2 Stock Trades Attract The Wrong Kind Of Attention: 'Should This Be Allowed?'
↗
March 19, 2024
Stock trades made by Senator Tommy Tuberville are drawing scrutiny on social media with potential conflicts of interest.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
March 01, 2024
Via
Benzinga
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
↗
March 01, 2024
Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than-expected third-quarter financial results and issued guidance.
Via
Benzinga
Humacyte's Earnings: A Preview
↗
November 08, 2023
Via
Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
March 01, 2024
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
March 01, 2024
Pre-market stock movers are worth checking on Friday as investors prepare for the last day of trading this week with all of the latest news!
Via
InvestorPlace
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
March 01, 2024
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday.
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
February 29, 2024
Via
Benzinga
Get Rich Quick With These 3 Penny Stocks to Buy Now
↗
February 12, 2024
Our economy has and will continue to show strength and resilience, you should invest in these three penny stocks to buy quick.
Via
InvestorPlace
Topics
Economy
Why Is Clinical-Stage Biotechnology Platform Company Humacyte Stock Gaining Friday?
↗
February 09, 2024
Humacyte's shares surge as FDA grants Priority Review to its BLA for Human Acellular Vessel (HAV) used in urgent arterial repair.
Via
Benzinga
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
↗
January 31, 2024
U.S. stocks traded mostly lower, with the Nasdaq Composite falling over 200 points on Wednesday.
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
January 09, 2024
Via
Benzinga
10 Best Stock Traders In Congress In 2023 (Spoiler: Nancy Pelosi Is Back On The List)
↗
January 02, 2024
A new report highlights the 10 members of Congress who profited the most from the stock market in 2023.
Via
Benzinga
Tommy Tuberville Lost On Tesla Trade, Could Win Big On US Steel Trade: A Look At The Congress Trades Raising Eyebrows
↗
December 19, 2023
Senator Tommy Tuberville has been actively trading United State Steel stock and options ahead of a proposed buyout.
Via
Benzinga
Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference
November 24, 2023
From
Humacyte, Inc
Via
GlobeNewswire
Humacyte Announces Two Presentations at the VEITHsymposium® of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular Trauma
November 17, 2023
From
Humacyte, Inc
Via
GlobeNewswire
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
November 14, 2023
Via
ACCESSWIRE
Humacyte Third Quarter 2023 Financial Results and Business Update
November 09, 2023
From
Humacyte, Inc
Via
GlobeNewswire
Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 9, 2023
November 02, 2023
From
Humacyte, Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
